Medical Properties Trust Inc. (NYSE:MPW) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday. The brokerage currently has a $16.00 price objective on the real estate investment trust’s stock. Zacks Investment Research’s target price would suggest a potential upside of 11.65% from the company’s current price.

According to Zacks, “Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional and community hospitals, women’s and children’s hospitals, skilled nursing facilities, ambulatory surgery centers, and other single-discipline healthcare facilities, such as heart hospitals, orthopedic hospitals and cancer centers. “

Other research analysts have also issued reports about the stock. TheStreet upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Tuesday, June 21st. Deutsche Bank AG assumed coverage on shares of Medical Properties Trust in a report on Friday, July 22nd. They set a “buy” rating and a $17.00 price objective on the stock. Wells Fargo & Co. reiterated a “hold” rating on shares of Medical Properties Trust in a report on Sunday, September 4th. JMP Securities lowered shares of Medical Properties Trust from an “outperform” rating to a “market perform” rating in a report on Friday, July 1st. Finally, BTIG Research assumed coverage on shares of Medical Properties Trust in a report on Thursday, August 25th. They set a “neutral” rating on the stock. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $14.17.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/medical-properties-trust-inc-mpw-upgraded-to-buy-at-zacks-investment-research.html

Medical Properties Trust (NYSE:MPW) opened at 14.33 on Wednesday. The company has a 50-day moving average of $15.05 and a 200-day moving average of $14.34. Medical Properties Trust has a 52 week low of $9.61 and a 52 week high of $15.92. The stock has a market cap of $3.41 billion, a P/E ratio of 17.52 and a beta of 1.02.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, August 4th. The real estate investment trust reported $0.32 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.32. The company had revenue of $126.30 million for the quarter, compared to analyst estimates of $128.04 million. Medical Properties Trust had a net margin of 38.03% and a return on equity of 9.06%. The firm’s quarterly revenue was up 26.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.30 EPS. On average, analysts predict that Medical Properties Trust will post $1.30 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 13th. Investors of record on Thursday, September 15th will be given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a yield of 6.42%. The ex-dividend date is Tuesday, September 13th. Medical Properties Trust’s dividend payout ratio (DPR) is presently 115.00%.

In other Medical Properties Trust news, Director G Steven Dawson sold 10,000 shares of the stock in a transaction that occurred on Friday, August 19th. The shares were sold at an average price of $15.36, for a total value of $153,600.00. Following the completion of the sale, the director now owns 67,729 shares of the company’s stock, valued at $1,040,317.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Edward K. Aldag, Jr. sold 50,000 shares of the stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $15.52, for a total transaction of $776,000.00. Following the completion of the sale, the chairman now directly owns 1,927,313 shares of the company’s stock, valued at approximately $29,911,897.76. The disclosure for this sale can be found here. Corporate insiders own 1.44% of the company’s stock.

A number of hedge funds have recently modified their holdings of the stock. BNP Paribas Arbitrage SA increased its stake in shares of Medical Properties Trust by 220.5% in the second quarter. BNP Paribas Arbitrage SA now owns 111,045 shares of the real estate investment trust’s stock valued at $1,689,000 after buying an additional 76,397 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Medical Properties Trust by 8,273.8% in the first quarter. JPMorgan Chase & Co. now owns 165,801 shares of the real estate investment trust’s stock valued at $2,152,000 after buying an additional 163,821 shares during the period. Teachers Advisors Inc. increased its stake in shares of Medical Properties Trust by 6.5% in the first quarter. Teachers Advisors Inc. now owns 351,570 shares of the real estate investment trust’s stock valued at $4,563,000 after buying an additional 21,498 shares during the period. AXA increased its stake in shares of Medical Properties Trust by 202.4% in the first quarter. AXA now owns 491,479 shares of the real estate investment trust’s stock valued at $6,380,000 after buying an additional 328,970 shares during the period. Finally, State Street Corp increased its stake in shares of Medical Properties Trust by 4.2% in the first quarter. State Street Corp now owns 5,813,219 shares of the real estate investment trust’s stock valued at $75,453,000 after buying an additional 236,692 shares during the period. 81.48% of the stock is owned by institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust (REIT) focused on investing in and owning net-leased healthcare facilities. It conducts all of its business through MPT Operating Partnership, L.P. It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases.

5 Day Chart for NYSE:MPW

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.